ARCHIVES

SEC Notifies ImClone It May Bring Action Against Company

This article is from The Cancer Letter archive.

Vol. 28 No. 25 | June 21, 2002

Download PDF Visit The Full Archive

Related Articles

Gleevec To Prevent Recurrence Of Gastrointestinal Cancer

December 26, 2008

Intarferon Results Promising, ACS Says, And commits Another $3.4 Million

February 22, 1980

Turnover In Immunology Contracts To Free Up Substantial Sums, Possible New RFPs Listed

October 8, 1976

St. Jude Offers Three Fellowships

March 2, 1984

Consensus Conference On Receptors Planned

June 22, 1979

Personal letters: mixed reviews of Donald Pinkel’s article on Childhood Lymphocytic Leukemia

May 6, 2021